Encompass Health Corporation $EHC Shares Sold by Reinhart Partners LLC.

Key Points

• Reinhart Partners LLC reduced its stake in Encompass Health Corporation by 19.5%, currently holding approximately 1.9% of the company's stock, worth about $55.6 million.
• Institutional investors now own 97.25% of Encompass Health, with several funds increasing their positions significantly during the first quarter of the year.
• The company recently declared a quarterly dividend increase to $0.19 per share, raising its annualized dividend yield to 0.6%.

Reinhart Partners LLC. reduced its stake in Encompass Health Corporation (NYSE:EHC - Free Report) by 19.5% in the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 453,119 shares of the company's stock after selling 109,849 shares during the quarter. Encompass Health makes up approximately 1.9% of Reinhart Partners LLC.'s investment portfolio, making the stock its 27th largest position. Reinhart Partners LLC. owned about 0.45% of Encompass Health worth $55,568,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors also recently added to or reduced their stakes in the company. Cetera Investment Advisers lifted its stake in shares of Encompass Health by 7.7% in the 4th quarter. Cetera Investment Advisers now owns 14,515 shares of the company's stock valued at $1,340,000 after purchasing an additional 1,036 shares during the last quarter. Deutsche Bank AG lifted its stake in shares of Encompass Health by 9.9% in the 4th quarter. Deutsche Bank AG now owns 9,814 shares of the company's stock valued at $906,000 after purchasing an additional 883 shares during the last quarter. Focus Partners Wealth acquired a new position in shares of Encompass Health in the 4th quarter valued at $649,000. Gotham Asset Management LLC acquired a new position in shares of Encompass Health in the 4th quarter valued at $505,000. Finally, Man Group plc lifted its stake in shares of Encompass Health by 53.1% in the 4th quarter. Man Group plc now owns 55,407 shares of the company's stock valued at $5,117,000 after purchasing an additional 19,217 shares during the last quarter. 97.25% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling at Encompass Health

In other news, EVP Patrick William Tuer sold 1,020 shares of the business's stock in a transaction on Wednesday, August 27th. The stock was sold at an average price of $123.59, for a total value of $126,061.80. Following the completion of the transaction, the executive vice president directly owned 18,846 shares of the company's stock, valued at $2,329,177.14. The trade was a 5.13% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. 2.00% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

EHC has been the topic of several recent analyst reports. Stephens raised Encompass Health from an "overweight" rating to a "strong-buy" rating and set a $135.00 price target on the stock in a research note on Thursday, June 5th. KeyCorp increased their target price on Encompass Health from $135.00 to $140.00 and gave the stock an "overweight" rating in a research note on Tuesday, September 16th. Wall Street Zen lowered Encompass Health from a "strong-buy" rating to a "buy" rating in a research note on Friday, June 6th. UBS Group increased their target price on Encompass Health from $130.00 to $140.00 and gave the stock a "buy" rating in a research note on Wednesday, August 6th. Finally, Bank of America increased their target price on Encompass Health from $145.00 to $160.00 and gave the stock a "buy" rating in a research note on Wednesday, September 10th. One research analyst has rated the stock with a Strong Buy rating and seven have given a Buy rating to the company's stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Buy" and a consensus target price of $138.43.

Encompass Health Stock Performance

NYSE:EHC traded down $1.39 during mid-day trading on Friday, reaching $123.94. 1,428,682 shares of the stock were exchanged, compared to its average volume of 602,788. The company has a 50 day simple moving average of $118.12 and a 200-day simple moving average of $113.71. The stock has a market capitalization of $12.48 billion, a P/E ratio of 24.25, a P/E/G ratio of 2.17 and a beta of 0.92. The company has a quick ratio of 1.06, a current ratio of 1.06 and a debt-to-equity ratio of 0.76. Encompass Health Corporation has a 1 year low of $87.85 and a 1 year high of $127.15.

Encompass Health (NYSE:EHC - Get Free Report) last released its quarterly earnings results on Monday, August 4th. The company reported $1.40 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.20 by $0.20. Encompass Health had a return on equity of 17.83% and a net margin of 9.22%.The firm had revenue of $1.46 billion for the quarter, compared to the consensus estimate of $1.43 billion. During the same quarter last year, the business posted $1.11 EPS. The firm's quarterly revenue was up 12.0% compared to the same quarter last year. Encompass Health has set its FY 2025 guidance at 5.120-5.340 EPS. Analysts anticipate that Encompass Health Corporation will post 4.8 earnings per share for the current fiscal year.

Encompass Health Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, October 15th. Stockholders of record on Wednesday, October 1st will be issued a $0.19 dividend. This represents a $0.76 dividend on an annualized basis and a dividend yield of 0.6%. This is a positive change from Encompass Health's previous quarterly dividend of $0.17. The ex-dividend date of this dividend is Wednesday, October 1st. Encompass Health's payout ratio is presently 13.31%.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.